Ibuprofen use and clinical outcomes in COVID-19 patients

OBJECTIVE: It was recently suggested that ibuprofen might increase the risk for severe and fatal coronavirus disease 2019 (COVID-19) and should therefore be avoided in this patient population. We aimed to evaluate whether ibuprofen use in individuals with COVID-19 was associated with more severe dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinott, E., Kozer, E., Shapira, Y., Bar-Haim, A., Youngster, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289730/
https://www.ncbi.nlm.nih.gov/pubmed/32535147
http://dx.doi.org/10.1016/j.cmi.2020.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289730/
https://www.ncbi.nlm.nih.gov/pubmed/32535147
http://dx.doi.org/10.1016/j.cmi.2020.06.003

Ejemplares similares